Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

Biotechnology 490 Arsenal Way 59 employees CLOSI
Employees
59
Contacts
2
Emails
2
Phones
2

Tectonic Therapeutic, Inc. Overview

Headquarters
490 Arsenal Way
Industry
Biotechnology
Employees
59
Founded
2019
Stock Symbol
CLOSI
Funding
185.0M

About Tectonic Therapeutic, Inc.

Tectonic is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors. We have developed a proprietary technology platform called GEODe™ to enable the discovery and development of GPCR-targeted biologic medicines that can modify the course of disease, by addressing challenges that have limited the pace of innovation in this field. Our focus is on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life.

Tectonic Therapeutic, Inc. Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
2
50.0% coverage

Tectonic Therapeutic, Inc. Org Chart

Sample employees and titles
Name Title Contact
Anthony (Tony) Muslin Chief Development Officer at Tectonic
Email Phone
Craig R. Ulmer Global Program/project Management
View
Phillip Donenberg Member of the Board of Directors
View
Geraldine Peters-Wiles, Ms, Sphr Builder - Learner - Teacher - Perfectly
Email Phone

Employees by Management Level

Individual contributor 7 profiles
Senior / Lead 3 profiles
Manager 2 profiles
Executive 1 profile
Director 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 1
Healthcare 3 3 1

Tectonic Therapeutic, Inc. Tech Stack

Data / AI 3 profiles

Compare Similar Companies to Tectonic Therapeutic, Inc.